DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Discover a study that explores how a personalised mHealth exercise program can effectively improve ADHD symptoms in children.

ELTP posts record fiscal 2025 revenues and operating income gains, fueled by new launches and expanding generics market share ...

Physical activity volume was positively associated with ADHD symptoms while variability was negatively associated with ADHD symptoms.

Aytu BioPharma, Inc. (NASDAQ:AYTU) is among the best growth stocks to invest in for the next 5 years. On Monday, Aytu ...

The FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...

Growing reliance on AI tools like ChatGPT for mental health raises concerns about replacing professional therapy, experts ...

There are many disconnects between what the Trump administration says about health and what it’s actually doing, scientists ...